Tracking and Evaluation Core

太平洋创新、知识和创新中心的跟踪和评估(TE)核心的目的 机会(PIKO)是监测和指导合作机构-夏威夷大学(UH)，夏威夷 太平洋大学和火奴鲁鲁夏米纳德大学(CUH)--努力改善 原住民太平洋人(IPP)，定义为原住民夏威夷人、其他太平洋岛民和菲律宾人。这些 努力需要高质量、持续的执行评估、高效的管理和可证明的 有效性。Piko TE Core采用基于团队的方法来评估其他核心的努力- 行政管理；生物统计学、流行病学和研究设计；专业发展；试点项目 计划；社区参与和外展；临床研究和监管支持。 TE核心是由疾病控制和预防中心的项目评估框架指导的。 将进行形成性、过程、结果和影响评估，以确保里程碑和基准 已实现。该方法还将评估PIKO的计划、资源、服务、翻译活动和 临床和转化性研究(CTR)领域的总体进展，最终目标是改进 IPP健康。应用的是传统混合方法与土著方法的精选方面的混合 评估和创新方法，如社会网络分析和可持续性指数，以确定 健康指标随时间变化的程度。经济评估将检查投资回报。 关于PIKO的试点和外部赞助的与赠款有关的活动和成果。TE核心的具体目标 具体情况如下： 具体目标1：通过分析业绩跟踪和评价PIKO CTR的进展和生产率 用于进度报告的数据，并通过分析业绩，展示对联邦资金的合理管理 用于战略规划的数据，以加强活动，提高效率，并提供新的方向。 具体目标2：通过记录，跟踪和评价PIKO CTR的经验教训和最佳做法 每年为每个核心质量改进吸取一条经验教训，并记录一条 每个核心每年用于IDEA-CTR网络范围内的传播。 具体目标3：通过开展以下活动跟踪和评估PIKO CTR的公共健康和经济影响 严格的经济分析，以确定核心活动的投资回报率，并进行全州健康调查分析 数据，以确定在健康结果方面取得的进展。 TE核心将由Angela Sy领导，DrPH是UH在评估研究项目方面经验丰富的IPP， 华盛顿州立大学的Dedra Buchwald医学博士，Spero Manson博士， 作为顾问的科罗拉多大学安舒茨医学中心和乔纳森·贝克博士，首席评估者 哈佛大学霍华德·休斯医学院包容性卓越计划。

The purpose of the Tracking and Evaluation (TE) Core of the Center for Pacific Innovations, Knowledge, and Opportunities (PIKO) is to monitor and guide the partner institutions – the University of Hawaii (UH), Hawaii Pacific University, and Chaminade University of Honolulu (CUH) – in their efforts to improve the health of Indigenous Pacific People (IPP), defined as Native Hawaiians, Other Pacific Islanders, and Filipinos. These efforts require high‐quality, continual assessment of implementation, efficient management, and demonstrable effectiveness. PIKO TE Core incorporates a team-based approach to evaluating the efforts of the other Cores – Administrative; Biostatistics, Epidemiology, and Research Design; Professional Development; Pilot Projects Program; Community Engagement and Outreach; and Clinical Research and Regulatory Support. The TE Core is guided by the Centers for Disease Control and Prevention’s Program Evaluation Framework. Formative, process, outcome, and impact evaluations will be done to ensure milestones and benchmarks are achieved. This approach will also assess PIKO’s programs, resources, services, translational activities, and overall progress along the clinical and translational research (CTR) spectrum, with the ultimate goal of improving IPP health. Applied are a blend of conventional mixed-methods with selected aspects of Indigenous approaches to evaluation and innovative methods, such as social network analysis and sustainability indices, to determine the extent of change over time in health indicators. An economic evaluation will examine the return on investment of PIKO’s pilot and externally sponsored grant-related activities and outcomes. The Specific Aims of the TE Core are as follow: Specific Aim 1: Track and evaluate progress and productivity of PIKO CTR by analyzing performance data for progress reports and demonstrate sound stewardship of federal funds and by analyzing performance data for strategic planning to strengthen activities, enhance efficiency, and inform new directions. Specific Aim 2: Track and evaluate lessons learned and best practices of PIKO CTR by documenting one lesson learned for each core annually for quality improvement and by documenting one best practice for each core annually for IDeA-CTR network-wide dissemination. Specific Aim 3: Track and evaluate public health and economic impact of PIKO CTR by conducting rigorous economic analysis to ascertain ROI of core activities and conduct analysis of statewide health survey data to ascertain gains in health outcomes. The TE Core will be led by Angela Sy, DrPH, a IPP at UH experienced in evaluating research programs, assisted by Dedra Buchwald, MD, from the Washington State University, Spero Manson, PhD, from the University of Colorado Anschutz Medical Center, as consultants, and Jonathan Baker, PhD, lead evaluator of the Howard Hughes Medical Institute Inclusive Excellence Initiative at CUH.